FR2453853A1 - Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation - Google Patents

Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation

Info

Publication number
FR2453853A1
FR2453853A1 FR8007993A FR8007993A FR2453853A1 FR 2453853 A1 FR2453853 A1 FR 2453853A1 FR 8007993 A FR8007993 A FR 8007993A FR 8007993 A FR8007993 A FR 8007993A FR 2453853 A1 FR2453853 A1 FR 2453853A1
Authority
FR
France
Prior art keywords
hydrogen atom
diphenylmethylpiperidino
alcanophenones
antihistamins
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8007993A
Other languages
English (en)
Other versions
FR2453853B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of FR2453853A1 publication Critical patent/FR2453853A1/fr
Application granted granted Critical
Publication of FR2453853B1 publication Critical patent/FR2453853B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LES NOUVEAUX MEDICAMENTS SELON L'INVENTION CONSISTENT EN COMPOSES DE FORMULE GENERALE: (CF DESSIN DANS BOPI) DANS LAQUELLE R REPRESENTE UN ATOME D'HYDROGENE OU UN GROUPE HYDROXY, R REPRESENTE UN ATOME D'HYDROGENE, OU BIEN R ET R PRIS ENSEMBLE FORMENT UNE SECONDE LIAISON ENTRE LES ATOMES DE CARBONE PORTANT R ET R, N EST UN ENTIER DE 1 A 5, R EST UN GROUPE -CH, -CHOH, -COOH OU -COO ALKYLE, DANS LEQUEL LE RESTE ALKYLE EST A CHAINE DROITE OU RAMIFIEE EN C-C, A ET B REPRESENTENT CHACUN UN ATOME D'HYDROGENE OU UN GROUPE HYDROXY, AVEC LES CONDITIONS QUE L'UN AU MOINS DES RESTES A ET B EST UN ATOME D'HYDROGENE ET L'UN DES RESTES A ET B EST AUTRE QUE L'HYDROGENE LORSQUE R EST UN GROUPE CH; ET LEURS SELS D'ADDITION D'ACIDES. ON PEUT LES ADMINISTRER A DES DOSES JOURNALIERES D'ENVIRON 0,01 A 20MGKG DE POIDS CORPOREL, PAR EXEMPLE EN TABLETTES, CONTENANT 1 A 50MG D'INGREDIENT ACTIF, 1 A 4 FOIS PAR JOUR.
FR8007993A 1979-04-10 1980-04-09 Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation Granted FR2453853A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/028,872 US4254130A (en) 1979-04-10 1979-04-10 Piperidine derivatives

Publications (2)

Publication Number Publication Date
FR2453853A1 true FR2453853A1 (fr) 1980-11-07
FR2453853B1 FR2453853B1 (fr) 1982-07-09

Family

ID=21845986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8007993A Granted FR2453853A1 (fr) 1979-04-10 1980-04-09 Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation

Country Status (18)

Country Link
US (1) US4254130A (fr)
JP (1) JPS55139360A (fr)
AT (1) AT376207B (fr)
AU (1) AU536463B2 (fr)
BE (1) BE882704A (fr)
CA (1) CA1123439A (fr)
CH (1) CH648019A5 (fr)
DE (1) DE3005948A1 (fr)
DK (1) DK160250C (fr)
ES (1) ES489933A0 (fr)
FR (1) FR2453853A1 (fr)
IL (1) IL59157A (fr)
IT (1) IT1144079B (fr)
NL (1) NL190664C (fr)
NO (1) NO154964C (fr)
NZ (1) NZ192615A (fr)
SE (1) SE448727B (fr)
ZA (1) ZA80331B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0723958A1 (fr) * 1993-06-24 1996-07-31 Albany Molecular Research, Inc. Synthèse de dérivés de terfenadine effectivement purs

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231105A (en) * 1987-06-02 1993-07-27 Ajinomoto Co., Inc. Ethylamine derivatives and antihypertensives containing the same
DE3917241A1 (de) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
JP2548800Y2 (ja) * 1991-09-13 1997-09-24 株式会社小糸製作所 自動車用ヘッドランプ
HU211019B (en) * 1991-12-02 1995-09-28 Richter Gedeon Vegyeszet Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
WO1993021156A1 (fr) * 1992-04-10 1993-10-28 Merrell Dow Pharmaceuticals Inc. Derives de piperidine 4-diphenymethylique et leur procede de preparation
US5631375A (en) * 1992-04-10 1997-05-20 Merrell Pharmaceuticals, Inc. Process for piperidine derivatives
US5654433A (en) * 1993-01-26 1997-08-05 Merrell Pharmaceuticals Inc. Process for piperidine derivatives
US20020007068A1 (en) 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
ATE230395T1 (de) 1993-06-25 2003-01-15 Merrell Pharma Inc Neue zwischenprodukte für die herstellung von antihistaminschen 4- diphenylmethyl/diphenylmethoxypiperidin-derivat n
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
CA2449419C (fr) 1994-05-18 2011-09-06 Aventis Pharmaceuticals Inc. Methodes pour preparer des formes anhydres et hydratees de derives antihistaminiques de la piperidine; leurs formes polymorphes et pseudomorphes
CN1067385C (zh) 1994-08-25 2001-06-20 默里尔药物公司 用于治疗变应性疾病的新的取代的哌啶类化合物
EP0812195B1 (fr) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Composition pharmaceutique pour composes de piperidinoalcanol
WO1996035667A1 (fr) * 1995-05-08 1996-11-14 Hoescht Marion Roussel, Inc. Derives butanol d'alpha-(alkylphenyl substitue)-4-(hydroxydiphenylmethyl)-1-piperidine, leur preparation et leur utilisation en tant qu'agents antihistaminiques, antiallergiques et dilatateurs bronchiques
US5574045A (en) * 1995-06-06 1996-11-12 Hoechst Marion Roussel, Inc. Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
US6211199B1 (en) 1995-11-17 2001-04-03 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
US6194406B1 (en) 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6201124B1 (en) * 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6153754A (en) 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5998439A (en) 1996-02-21 1999-12-07 Hoescht Marion Roussel, Inc. Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
US5922737A (en) * 1996-02-21 1999-07-13 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
US5932571A (en) * 1996-02-21 1999-08-03 Hoechst Marion Roussel, Inc. Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
IL133420A (en) * 1997-08-26 2004-07-25 Aventis Pharma Inc Tablet-shaped pharmaceutical preparation containing a combination of piperidinoalkanol and antihistamines and reduces symptomatic congestion
US6689898B2 (en) 1998-07-02 2004-02-10 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6683094B2 (en) 1998-07-02 2004-01-27 Aventis Pharmaceuticals Inc. Antihistaminic piperidine derivatives and intermediates for the preparation thereof
US6613907B2 (en) 2000-11-08 2003-09-02 Amr Technology, Inc. Process for the production of piperidine derivatives with microorganisms
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
EP1616861A3 (fr) * 2004-06-15 2006-02-08 Dipharma S.p.A. Procédé de préparation de composés cétoniques
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
EP2218442A1 (fr) 2005-11-09 2010-08-18 CombinatoRx, Inc. Procédés, compositions et kits pour le traitement des maladies ophthalmiques
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
WO2008033466A2 (fr) * 2006-09-14 2008-03-20 Combinatorx (Singapore) Pre. Ltd. Compositions et procédés pour le traitement de maladies virales
ITMI20070987A1 (it) * 2007-05-16 2008-11-17 Dipharma Francis Srl Procedimento per la preparazione di composti chetonici
WO2010021681A2 (fr) * 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions et procédés pour le traitement de maladies virales
EP2289867A3 (fr) 2009-08-19 2012-04-25 Jubilant Organosys Limited Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
EP2371817A1 (fr) 2010-04-01 2011-10-05 Arevipharma GmbH Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
EP2578570A1 (fr) 2011-10-07 2013-04-10 Almirall, S.A. Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
EP2641900A1 (fr) 2012-03-20 2013-09-25 Almirall, S.A. Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
CN116375634A (zh) * 2023-01-03 2023-07-04 成都施贝康生物医药科技有限公司 卡瑞斯汀对甲苯磺酸盐的晶型和无定型

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
FR2260349A2 (fr) * 1974-02-08 1975-09-05 Richardson Merrell Inc
FR2262986A1 (fr) * 1974-03-04 1975-10-03 Richardson Merrell Inc

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
US3965257A (en) * 1972-01-28 1976-06-22 Richardson-Merrell Inc. Compositions and methods for the treatment of the symptoms of histamine induced allergic reactions
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
BE794596A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Piperidinoalcanone-oximes substituees et leur procede de preparation
ZA728544B (en) * 1972-01-28 1974-02-27 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3941795A (en) * 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US3922276A (en) * 1974-12-11 1975-11-25 Robins Co Inc A H 1-Substituted-4-benzylidenepiperidines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
FR2260349A2 (fr) * 1974-02-08 1975-09-05 Richardson Merrell Inc
FR2262986A1 (fr) * 1974-03-04 1975-10-03 Richardson Merrell Inc

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0723958A1 (fr) * 1993-06-24 1996-07-31 Albany Molecular Research, Inc. Synthèse de dérivés de terfenadine effectivement purs
EP1026147A1 (fr) * 1993-06-24 2000-08-09 Albany Molecular Research, Inc. Composés qui sont utilisés comme intermediaires pour la préparation de dérivés de piperidine

Also Published As

Publication number Publication date
ES8103734A1 (es) 1981-03-16
ES489933A0 (es) 1981-03-16
JPS55139360A (en) 1980-10-31
FR2453853B1 (fr) 1982-07-09
DK160250B (da) 1991-02-18
DE3005948C2 (fr) 1989-10-05
IL59157A0 (en) 1980-05-30
IT1144079B (it) 1986-10-29
BE882704A (fr) 1980-07-31
CA1123439A (fr) 1982-05-11
NO154964B (no) 1986-10-13
AU5501880A (en) 1980-10-16
CH648019A5 (de) 1985-02-28
IT8047919A0 (it) 1980-02-15
SE8002635L (sv) 1980-10-11
IL59157A (en) 1984-02-29
DK160250C (da) 1991-07-22
ATA126080A (de) 1984-03-15
NO154964C (no) 1987-01-21
NL190664C (nl) 1994-06-16
NL8000762A (nl) 1980-10-14
US4254130A (en) 1981-03-03
DE3005948A1 (de) 1980-10-30
NZ192615A (en) 1982-02-23
AU536463B2 (en) 1984-05-10
NO801015L (no) 1980-10-13
SE448727B (sv) 1987-03-16
ZA80331B (en) 1981-01-28
DK133080A (da) 1980-10-11
AT376207B (de) 1984-10-25
NL190664B (nl) 1994-01-17

Similar Documents

Publication Publication Date Title
FR2453853A1 (fr) Nouveaux derives d'o-(4-diphenylmethylpiperidino)-alcanophenones utiles notamment comme antihistaminiques, et leur procede de preparation
FR2453854A1 (fr) Nouveaux derives d'o-(4-diphenylmethylpiperidino)-1-phenylalcanols, utiles notamment comme antihistaminiques, et leur procede de preparation
CA2070388C (fr) Compositions antihypertensives et leur utilisation
FR2438651A1 (fr) Nouveaux derives d'indole utiles comme medicaments, procedes pour leur preparation et compositions pharmaceutiques les contenant
KR890701562A (ko) 면역조절 아자스 피란류
BE900345A (fr) Composition pharmaceutique ophtalmiques a base d'un derive d'acide phenylacetique.
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
IE39898B1 (en) 1-or 7-oxoalkyl xanthine derivatives
HUT38256A (en) Process for producing combined pharmaceutical compositions containing xantine derivatives and o-acetyl-salicylic acid or pharmaceutically acceptables salts
GB2071088B (en) Indane derivatives
US3950418A (en) Vitamin A acid amides
BE904368A (fr) Nouveaux derives de pyridylmethoxy- et methylmercaptoanilines, utiles notamment comme antiasthmatiques, leur fabrication et medicaments les contenant.
FR2447376A1 (fr) Nouveaux derives de 1,2-dihydro-2-oxo-4-phenyl-3-quinoleinecarbonitrile, utiles notamment comme agents anti-inflammatoires
FR2413389A1 (fr) Composes a tete de pont azotee ayant une action anti-allergique et procede pour leur preparation
FR2448531A1 (fr) Nouveaux derives de 4-(naphtylmethyl)piperidine, utiles notamment comme agents antipsychotiques et leur procede de preparation
ES2087252T3 (es) Uso de derivados de dioxabiciclo(3.3.0)octano para la preparacion de un medicamento para inhibir el metabolismo del colesterol.
FR2453866A1 (fr) Derives peptidiques, procede pour leur preparation et leur application dans des preparations pharmaceutiques
FR2637286A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2422405A1 (fr) Nouveaux medicaments constitues de derives de l'acide p-aminobenzoique
FR2375222A1 (fr) Nouveaux composes du type (2-benzothiazolyl)oxamate, leur procede de preparation et medicament les contenant
ATE149165T1 (de) Stickstoff enthaltende bizyklische derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
FR2413358A1 (fr) Nouveaux derives de 2-aminomethylphenol, utiles notamment comme agents anti-inflammatoires, et leur procede de preparation
ES8308833A1 (es) "un metodo para la preparacion de 3-fenil-1-indanaminas".
FR2691149B1 (fr) Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
FR2408591A1 (fr) 4-aroyl-4-hydroxypiperidines substituees en position 1, leurs sels d'addition avec des acides, utilisables comme medicaments antipsychotiques